2262-3035 Screening compound: N-(4-{N'-[(E)-(5-BROMO-2-METHOXYPHENYL)METHYLIDENE]HYDRAZINECARBONYL}PHENYL)-2-CHLOROBENZAMIDE

2262-3035 Screening compound: N-(4-{N'-[(E)-(5-BROMO-2-METHOXYPHENYL)METHYLIDENE]HYDRAZINECARBONYL}PHENYL)-2-CHLOROBENZAMIDE
2262-3035 Screening compound: N-(4-{N'-[(E)-(5-BROMO-2-METHOXYPHENYL)METHYLIDENE]HYDRAZINECARBONYL}PHENYL)-2-CHLOROBENZAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound 2262-3035
N-(4-{N'-[(E)-(5-BROMO-2-METHOXYPHENYL)METHYLIDENE]HYDRAZINECARBONYL}PHENYL)-2-CHLOROBENZAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2262-3035

Molecular Formula

C22H17BrClN3O3 (C22 H17 BrClN3 O3)

Compound Name

N-(4-{N'-[(E)-(5-BROMO-2-METHOXYPHENYL)METHYLIDENE]HYDRAZINECARBONYL}PHENYL)-2-CHLOROBENZAMIDE

IUPAC name

n/a

SMILES

COc(cc1)c(/C=N/NC(c(cc2)ccc2NC(c(cccc2)c2Cl)=O)=O)cc1Br

InChI

InChI=1S/C22H17BrClN3O3/c1-30-20-11-8-16(23)12-15(20)13-25-27-21(28)14-6-9-17(10-7-14)26-22(29)18-4-2-3-5-19(18)24/h2-13H,1H3,(H,26,29)(H,27,28)

InChI Key

QVFDHSDUKCQWOQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01840447

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

486.75

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.441

Distribution Coefficient, logD

5.358

Water Solubility, LogSw

-5.82

Polar Surface Area

66.276

Acid Dissociation Constant (pKa)

8.08

Base Dissociation Constant (pKb)

-0.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.50

2262-3035 in Drug Discovery

Included in Screening Libraries

Integrin Receptors Targeted library (1715 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with 2262-3035 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2262-3035?
Check Price and Availability of 2262-3035, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2262-3035 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2262-3035
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2262-3035
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2262-3035 available by request